Comments

Champions Oncology Stock Guidance

CSBRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Champions Oncology (CSBR) Forecast News Earnings Champions Oncology (CSBR) Options

Guidance

Dividends Analyst Ratings Insider Trades Short Interest

Champions Oncology Stock Guidance | NASDAQ:CSBR | Benzinga

Champions Oncology issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
07/21/2022	CSBR	Champions Oncology	FY	2023	—	—	—	$58.93M	$58.93M	$57.19M	Get Alert
03/15/2022	CSBR	Champions Oncology	FY	2022	—	—	—	$47.20M	$49.25M	$48.29M	Get Alert
12/14/2020	CSBR	Champions Oncology	FY	2021	—	—	—	$38.55M	$40.15M	$38.56M	Get Alert

FAQ

Q

What is the most recent guidance for Champions Oncology (CSBR)?

A

There have been no specific sales or earnings guidance reported for Champions Oncology in recent months.

Browse guidance and forecast on all stocks.

People Also Watch